Global Ablation Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global ablation market in its upcoming report titled, “Global Ablation Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global ablation market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global ablation market report has been segmented on the basis of technology, application, and region.

Request Covid - 19 Impact

Ablation is a treatment to cure various tumors such as lung, bone, kidney, etc. It is minimal invasive technique and better option for people who have failed chemotherapy or radiotherapy or are not fit for surgical due to poor health condition.

Increasing incidences of chronic diseases such as cancer, cardiovascular diseases, etc. and increasing demand for minimally invasive procedures with fast recovery are major factors driving growth of the global ablation market. In addition, increasing ablation treatment applications in pain management, cosmetic surgery, fecal incontinence, etc. is another factor expected to boost growth of the global ablation market. Moreover, increasing government initiatives regarding awareness of ablation treatment and increasing expenditure on healthcare sector is expected to support growth of the global ablation market.

Though ablation is safe and does not have any side-effects, yet it is possible that it has adverse effects such as infection on liver and abdominal pain, which is expected to challenge growth of the ablation market to certain extent.

North America market is expected to dominate in the global ablation market with higher market share as compared to other regional markets, and is expected to continue its dominance during the forecast period. This can be attributed to rising preference for minimally invasive procedures, increasing number of patients suffering from chronic disease, and well-developed healthcare sector in countries in the region. Europe market accounts for second-largest revenue share in the global ablation market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing government expenditure on healthcare infrastructure and rising awareness regarding ablation treatment in emerging economies in this region.

Global Ablation Market Segmentation:

By Technology:

• Radiofrequency ablation (RFA)
• Ethanol (alcohol) ablation
• Microwave thermotherapy
• Cryosurgery (cryotherapy)

By Application:

• Cardiovascular Disease
• Cancer
• Ophthalmology
• Pain Management
• Gynecology
• Urology
• Orthopedic Treatment
• Cosmetic Surgery
• Others (fecal incontinence, gastroesophageal reflux disease (GERD), tonsillectomy, psoriasis)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Medtronic, Inc.
• Biosense Webster, Inc.
• Jude Medical, Inc.
• Boston Scientific Corporation
• CONMED Corporation
• AngioDynamics, Inc.
• AtriCure, Inc.
• Smith & Nephew plc
• Olympus Corporation